Companies /Healthcare

Turn Therapeutics Inc. Common Stock

NASDAQ: TTRX Biotechnology
$13.33
▲ $0.02 (+0.15%) today
Markets closed · 1:16pm ET

Fundamentals

Market Cap
$404.8M
EPS (TTM)
$-0.28
52-Week Range
$3 – $16
Street Target
$25.00

About Turn Therapeutics

Turn Therapeutics Inc. (Ticker: TTRX) is a forward-thinking pharmaceutical company headquartered in Westlake Village, California, dedicated to pioneering innovative therapies for skin, nail, and ocular diseases. By harnessing state-of-the-art research and technology, the company targets significant unmet medical needs in these specialty areas, aiming to deliver transformative treatments that enhance patient outcomes. With a strong commitment to improving the quality of life for patients suffering from chronic conditions, Turn Therapeutics is well-positioned to make impactful contributions to the healthcare landscape.

TTRX Coverage